tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX

Compare Lineage Therap (LCTX) vs. Competitors

Compare
2,051 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lineage Therap
$1.67
$405.38M
-5.63
179.26%
4 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$15.16
$323.62M
-3.64
47.27%
0 Buy
0 Hold
1 Sell
Moderate Sell
Tvardi Therapeutics
$4.56
$42.12M
-0.46
-67.38%
2 Buy
3 Hold
0 Sell
Moderate Buy
DBV Technologies SA - American
$17.03
$724.11M
-3.25
214.79%
5 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$7.86
$428.51M
-2.00
65.13%
7 Buy
1 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$5.06
$321.96M
-2.62
-32.53%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LCTX
Lineage Therap
1.67
1.10
192.98%
AMRN
Amarin
15.16
4.08
36.82%
TVRD
Tvardi Therapeutics
4.56
-9.24
-66.96%
DBVT
DBV Technologies SA - American
17.03
12.30
260.04%
FDMT
4D Molecular Therapeutics
7.86
3.18
67.95%
AURA
Aura Biosciences Inc
5.06
-2.61
-34.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts